In April xxxx, the US market for Benzalkonium Chloride (BAC) had faced volatile pricing due to a combination of supply chain actions, shifting demand from downstream industries, and escalating geopolitical tensions.
The beginning of April saw a sharp decline in BAC prices, driven largely by oversupplied inventories. Importers had frontloaded significant volumes of BAC earlier in the year in anticipation of heavier tariffs on Chinese goods. This stockup on the conservative side left a lot of players with a backup amount of inventory, causing a brief decrease in buying activity. Adding to the uncertainty, the U.S. administration鈥攗nder President Trump鈥攅nacted a tariff hike to xxxx on a wide range of Chinese goods, including chemical imports like BAC. The market responded with hesitation, as businesses awaited the outcomes of potential trade negotiations. Prices for BAC near the end of the...
